Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperactivity disorder (ADHD) in the Offspring: a True Effect or a Bias? A Systematic Review & Meta-Analysis

被引:24
|
作者
Leshem, Regina [1 ]
Bar-Oz, Benjamin [2 ]
Diav-Citrin, Orna [1 ,3 ]
Gbaly, Siham [1 ]
Soliman, Jessica [1 ]
Renoux, Christel [4 ]
Matok, Ilan [1 ]
机构
[1] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Ein Kerem Campus, Jerusalem, Israel
[2] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel
[3] Minist Hlth, Israeli Teratol Informat Serv, Jerusalem, Israel
[4] McGill Univ, Montreal, PQ, Canada
关键词
SSRI's; SNRI's; antidepressants; ASD; ADHD; prenatal exposure; pregnancy; MATERNAL ANTIDEPRESSANT USE; PLACENTAL-TRANSFER; PRETERM BIRTH; FUNNEL-PLOT; DEPRESSION; EXPOSURE; OUTCOMES;
D O I
10.2174/1570159X19666210303121059
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background and objective: An inconsistent association between exposure to SSRIs and SNRIs and the risk for ASD and ADHD in the Offspring was observed in observational studies. Some suggest that the reported association might be due to unmeasured confounding. We aimed to study this association and to look for sources of bias by performing a systematic review and meta-analysis. Methods: Medline, Embase, and the Cochrane Library were searched up to June 2019 for studies reporting on ASD and ADHD in the Offspring following exposure during pregnancy. We followed the PRISMA 2009 guidelines for data selection and extraction. Outcomes were pooled using random-effects models and odds ratios (OR), and 95% confidence intervals (CI) were calculated for each outcome using the adjusted point estimate of each study. Results: Eighteen studies were included in the meta-analysis. We found an association between SSRIs/SNRIs prenatal use and the risk for ASD and ADHD (OR=1.42, 95% CI: 1.23-1.65, I-2=58%; OR=1.26, 95% CI: 1.07-1.49, I-2=48%, respectively). Similar findings were obtained in women who were exposed to SSRIs/SNRIs before pregnancy, representing statistically significant association with ASD (OR=1.39, 95% CI: 1.24-1.56, I-2=33%) and ADHD (OR=1.63, 95% CI: 1.50-1.78, I-2=0%) in the Offspring, although they were not exposed to those medications in utero. Conclusions: Although we found an association between exposure to SSRIs/SNRIs during pregnancy and the risk for ASD and ADHD, an association with those disorders was also present for exposure pre-pregnancy, suggesting that the association might be due to unmeasured confounding. We are aiming to further assess the role of potential unmeasured confounding in the estimation of the association and perform a network meta-analysis.
引用
收藏
页码:896 / 906
页数:11
相关论文
共 50 条
  • [41] Prenatal cannabis use and the risk of attention deficit hyperactivity disorder and autism spectrum disorder in offspring: A systematic review and meta-analysis
    Tadesse, Abay Woday
    Dachew, Berihun Assefa
    Ayano, Getinet
    Betts, Kim
    Alati, Rosa
    JOURNAL OF PSYCHIATRIC RESEARCH, 2024, 171 : 142 - 151
  • [42] Systematic review of efficacy of selective serotonin reuptake inhibitors (SSRIs) compared to placebo in obsessive compulsive disorder (OCD) in adults
    Soomro, G. M.
    Altman, D.
    Rajagopal, S.
    Oakley-Browne, M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 283 - 283
  • [43] Alliance between selective serotonin reuptake inhibitors and fracture risk: an updated systematic review and meta-analysis
    Manoj Kumar
    Ram Bajpai
    Abdul Rahaman Shaik
    Swati Srivastava
    Divya Vohora
    European Journal of Clinical Pharmacology, 2020, 76 : 1373 - 1392
  • [44] Use of Selective Serotonin Reuptake Inhibitors and Risk of Upper Gastrointestinal Bleeding: A Systematic Review and Meta-analysis
    Jiang, Hai-Yin
    Chen, Hua-Zhong
    Hu, Xin-Jun
    Yu, Zheng-He
    Yang, Wei
    Deng, Min
    Zhang, Yong-Hua
    Ruan, Bing
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (01) : 42 - +
  • [45] ALLIANCE BETWEEN SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND FRACTURE RISK: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS
    Kumar, M.
    Bajpai, R.
    Shaik, A. R.
    Vohora, D.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S142 - S143
  • [46] Alliance between selective serotonin reuptake inhibitors and fracture risk: an updated systematic review and meta-analysis
    Kumar, Manoj
    Bajpai, Ram
    Shaik, Abdul Rahaman
    Srivastava, Swati
    Vohora, Divya
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (10) : 1373 - 1392
  • [47] The effect of selective serotonin and norepinephrine reuptake inhibitors on clinical outcome of COVID-19 patients: A systematic review and meta-analysis
    Firouzabadi, Dena
    Kheshti, Fatemeh
    Abdollahifard, Saeed
    Taherifard, Erfan
    Kheshti, Mohammad Reza
    HEALTH SCIENCE REPORTS, 2022, 5 (06)
  • [48] The Effectiveness of Selective Serotonin Reuptake Inhibitors for Treatment of Obsessive-Compulsive Disorder in Adolescents and Children: A Systematic Review and Meta-Analysis
    Kotapati, Vijaya Padma
    Khan, Ali M.
    Dar, Sara
    Begum, Guishan
    Bachu, Ramya
    Adnan, Mahwish
    Zubair, Aarij
    Ahmed, Rizwan A.
    FRONTIERS IN PSYCHIATRY, 2019, 10
  • [49] Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective-Serotonin Reuptake Inhibitors in Major Depressive Disorder
    Jakubovski, Ewgeni
    Varigonda, Anjali
    Freemantle, Nicholas
    Taylor, Matthew
    Bloch, Michael
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S500 - S501
  • [50] SSRIs During Pregnancy and Risk of Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder: Systematic Review of Observational Studies and Methodological Considerations
    Morales, Daniel R.
    Slattery, Jim
    Evans, Stephen
    Kurz, Xavier
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 418 - 419